CollPlant Biotechnologies
CLGN • NASDAQ
CollPlant Biotechnologies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Yehiel Tal, with a market cap of $8.0M.
CEOYehiel Tal
Next Earnings
Upcoming earnings announcement for CollPlant Biotechnologies
Date
Wednesday, May 27, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.24
Revenue Estimate
$1.4M
Earnings History
Past 12 earnings reports for CollPlant Biotechnologies
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.25Est: -$0.19 | -31.6% | $60.0KEst: $6.8M | -99.1% | — |
| Nov 26, 2025 | Q3 2025 | -$0.25Est: $0.25 | -200.0% | $77.0KEst: $13.7M | -99.4% | — |
| Aug 20, 2025 | Q2 2025 | -$0.23Est: $0.06 | -483.3% | $179.0KEst: $8.9M | -98.0% | — |
| May 28, 2025 | Q1 2025 | -$0.10Est: $0.00 | — | $2.1MEst: $9.8M | -78.9% | — |
| Mar 26, 2025 | Q4 2024 | -$0.30 | — | $164.0KEst: $358.4K | -54.2% | — |
| Nov 27, 2024 | Q3 2024 | -$0.33Est: -$0.37 | +10.8% | $4.0KEst: $730.0K | -99.5% | — |
| Aug 20, 2024 | Q2 2024 | -$0.33Est: -$0.35 | +5.7% | $249.0KEst: $700.0K | -64.4% | — |
| May 29, 2024 | Q1 2024 | -$0.35Est: -$0.35 | 0.0% | $98.0KEst: $600.0K | -83.7% | — |
| Apr 4, 2024 | Q4 2023 | -$0.35Est: -$0.07 | -400.0% | $299.0KEst: $8.6M | -96.5% | — |
| Nov 29, 2023 | Q3 2023 | -$0.35Est: -$0.13 | -169.2% | $43.0KEst: $3.5M | -98.8% | — |
| Aug 24, 2023 | Q2 2023 | $0.52Est: $0.01 | +5100.0% | $10.2MEst: $5.2M | +97.7% | — |
| May 24, 2023 | Q1 2023 | -$0.29Est: -$0.29 | 0.0% | $433.0KEst: $240.0K | +80.4% | — |